Clinical Trial Update: A Post Marketing Surveillance Study of Lipo-AB® (Amphotericin B) in Neutropenic Patients With Persistent Fever

View source ↗

Summary

This is a completed post-marketing surveillance trial evaluating Lipo-AB (Amphotericin B) in patients with febrile neutropenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Febrile Neutropenia

Drugs mentioned

• Lipo-AB (Amphotericin B)

Snippet

Sponsor: TTY Biopharm | Conditions: Neutropenia, Febrile | Status: COMPLETED